Results 1 to 10 of about 176,903 (205)
Revista Brasileira de Terapia Intensiva, 2008 JUSTIFICATIVA E OBJETIVOS: A pneumonia por Pneumocystis jirovecii tem sido uma das doenças mais comuns e uma complicação infecciosa fatal em pacientes com síndrome da imunodeficiência adquirida.
Élida Mara Carneiro +2 more
doaj +2 more sources
Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria [PDF]
Anais Brasileiros de Dermatologia, 2017 Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria. We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total
Sheng-Huei Wang +4 more
doaj +2 more sources
Intravenous trimethoprim–sulfamethoxazole desensitization as a therapeutic strategy for late-onset Pneumocystis jirovecii pneumonia in a kidney transplant recipient: a case report [PDF]
Journal of Medical Case ReportsBackground Pneumocystis jirovecii pneumonia is a potentially fatal opportunistic infection in kidney transplant recipients under intensified immunosuppression.
Banu Yılmaz
doaj +2 more sources
Avicenna Journal of Medicine, 2023 Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim +9 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma patients ...
Yan Xu +4 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan +8 more
doaj +1 more source
CONVENTIONAL METHODS FOR THE DIAGNOSIS OF PNEUMOCYSTIS JIROVECII IN IMMUNOCOMPROMISED IRAQI PATIENTS
The Iraqi Journal of Medical Sciences, 2016 Background: Pneumocystis jirovecii is the causative agent of pneumocystis pneumonia, one of the most frequent and severe opportunistic infections in immunocompromised patients.
Isa S. Touhali +2 more
doaj +6 more sources
Frontiers in Immunology, 2021 Pneumocystis jirovecii is one of the most common fungal pathogens in immunocompromised individuals. Pneumocystis jirovecii pneumonia (PJP) causes a significant host immune response that is driven greatly by the organism’s cell wall components including β-
Theodore J. Kottom +5 more
doaj +1 more source
Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!
Current Oncology, 2021 An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia.
Jérémy Barben +4 more
doaj +1 more source
Acta Médica Portuguesa, 2016 Introdução: A pneumonia por Pneumocystis jirovecii é das doenças infecciosas oportunistas mais comuns em infectados por vírus da imunodeficiência humana, sendo, actualmente, em Portugal a infecção definidora de sida mais reportada.
Vilma Grilo, Aida Pereira
doaj +1 more source